COVID-19 severity and corticosteroid treatment have minimal effect on specific antibody production

COVID-19 severity and corticosteroid treatment have minimal effect on specific antibody production

Abstract Background Dexamethasone is currently administered for Coronavirus disease 2019(COVID-19); however, there are concerns about its effect on specific antibodies’ production. The aim of this study was to evaluate whether specific antibodies were affected by COVID-19 severity and corticosteroid...

Celý popis

Podrobná bibliografie
Hlavní autoři: Takato Nakamoto, Noriko Iwamoto, Yusuke Oshiro, Natsumi Inamura, Takashi Nemoto, Satohi Ide, Keiji Nakamura, Hidetoshi Nomoto, Yutaro Akiyama, Tetsuya Suzuki, Yusuke Miyazato, Michiyo Suzuki, Kumiko Suzuki, Moto Kimura, Sho Saito, Satoshi Kutsuna, Norio Ohmagari
Médium: Článek
Jazyk:English
Vydáno: BMC 2024-10-01
Edice:BMC Infectious Diseases
Témata:
COVID-19
Specific antibody
Corticosteroids
Severity
On-line přístup:https://doi.org/10.1186/s12879-024-10090-z

Internet

https://doi.org/10.1186/s12879-024-10090-z

Podobné jednotky